Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 3/20 | 0.62 |
| ▸ | TSHR | P16473 | 3/20 | 0.62 |
| ▸ | HPGD | P15428 | 3/20 | 0.62 |
| ▸ | USP2 | O75604 | 2/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.57 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.57 |
| ▸ | MIF | P14174 | 1/20 | 0.55 |
| ▸ | LMNA | P02545 | 1/20 | 0.54 |
| ▸ | IDO1 | P14902 | 1/20 | 0.51 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17039271 | 0.84 | MAPK1 (0.62) | MAPK1TSHRHPGDUSP2ALDH1A1 | |
| SCHEMBL9364339 | 0.84 | MAPK1 (0.62) | MAPK1TSHRHPGDUSP2ALDH1A1 | |
| SCHEMBL4151771 | 0.81 | MAPK1 (0.68) | MAPK1TSHRHPGDUSP2ALDH1A1 | |
| SCHEMBL17036528 | 0.80 | MAPK1 (0.57) | MAPK1TSHRHPGDUSP2ALDH1A1 | |
| SCHEMBL3027838 | 0.80 | MAPK1 (0.66) | MAPK1TSHRHPGDUSP2ALDH1A1 | |
| SCHEMBL31236317 | 0.80 | MAPK1 (0.66) | MAPK1TSHRHPGDUSP2ALDH1A1 | |
| SCHEMBL9715926 | 0.79 | CBX7 (0.47) | MAPK1TSHRHPGDUSP2ALDH1A1 | |
| SCHEMBL9716064 | 0.79 | CD74 (0.57) | ALDH1A1MIFIDO1POLB | |
| SCHEMBL536309 | 0.79 | TDP1 (0.47) | HPGDALDH1A1MIFLMNAIDO1 | |
| SCHEMBL9716002 | 0.79 | MIF (0.44) | MIFIDO1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 114 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240215572-A1 | ANTIMICROBIAL PARTICLE DISPERSION | MITSUBISHI PENCIL COMPANY, LIMITED (JP) | 2024-07-04 | — | — | US | claimed |
| US-20170215421-A1 | BIOCIDE AGENTS | LANXESS DEUTSCHLAND GMBH (DE) | 2017-08-03 | — | — | US | claimed |
| EP-2779830-B1 | STABILIZATION OF COMPOUNDS CONTAINING IODINE HAVING POLYMERS COMPRISING NITROGEN | LANXESS DEUTSCHLAND GMBH (DE) | 2017-05-17 | — | — | EP | claimed |
| US-9585384-B2 | Stabilization of compounds comprising iodine | LANXESS DEUTSCHLAND GMBH (DE) | 2017-03-07 | — | — | US | claimed |
| EP-3125688-A1 | BIOCIDE AGENTS | LANXESS Deutschland GmbH (DE) | 2017-02-08 | — | — | EP | claimed |
| US-20160360753-A1 | BIOCIDIC MICROCAPSULES | LANXESS DEUTSCHLAND GMBH (DE) | 2016-12-15 | — | — | US | claimed |
| US-9326502-B2 | Stabilization of compounds containing iodine having polymers comprising nitrogen | LANXESS DEUTSCHLAND GMBH (DE) | 2016-05-03 | — | — | US | claimed |
| US-9328065-B2 | Nitrogen-containing inorganic carrier materials | LANXESS DEUTSCHLAND GMBH (DE) | 2016-05-03 | — | — | US | claimed |
| WO-2015150430-A1 | BIOCIDE AGENTS | LANXESS DEUTSCHLAND GMBH (DE) | 2015-10-08 | — | — | WO | claimed |
| EP-2926659-A1 | Biocidal agent | LANXESS Deutschland GmbH (DE) | 2015-10-07 | — | — | EP | claimed |
| WO-2011000794-A1 | POLYMERS CONTAINING HETEROCYCLIC 3-RING COMPOUNDS AND IODINE-CONTAINING COMPOUNDS | LANXESS DEUTSCHLAND GMBH (DE) | 2011-01-06 | — | — | WO | claimed |
| EP-2270087-A1 | Heterocyclic 3-ring connections and polymers containing iodine compounds | LANXESS Deutschland GmbH (DE) | 2011-01-05 | — | — | EP | claimed |
| WO-2010142790-A1 | INORGANIC CARRIER MATERIALS CONTAINING HETEROCYCLIC 3-RING COMPOUNDS | LANXESS DEUTSCHLAND GMBH (DE) | 2010-12-16 | — | — | WO | claimed |
| EP-1981629-A1 | IPBC-CONTAINING COACERVATES | Lanxess Deutschland GmbH (DE) | 2008-10-22 | — | — | EP | claimed |
| WO-2007087994-A1 | IPBC-CONTAINING COACERVATES | LANXESS DEUTSCHLAND GMBH (DE) | 2007-08-09 | — | — | WO | claimed |
| CN-1180477-A | Halopropargyl compounds as marine antifouling agents | ROHM & HAAS (US) | 1998-05-06 | — | — | CN | claimed |
| EP-0835604-A1 | Halopropargyl compounds as marine antifouling agents | ROHM AND HAAS COMPANY (US) | 1998-04-15 | — | — | EP | claimed |
| CN-1066758-A | Contain the antimicrobial compositions of iodopropargyl compound and isothiazolone and the method for controlling microbial | ROHM & HAAS (US) | 1992-12-09 | — | — | CN | claimed |
| US-5156665-A | ANTIMICROBIAL COMPOSITIONS COMPRISING IODOPROPARGYL COMPOUNDS AND ISOTHIAZOLONES AND METHODS OF CONTROLLING MICROBES | ROHM AND HAAS COMPANY (US) | 1992-10-20 | — | — | US | claimed |
| EP-0493969-A1 | Antimicrobial compositions comprising iodopropargyl compounds and isothiazolones | ROHM AND HAAS COMPANY (US) | 1992-07-08 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240215572-A1 | ANTIMICROBIAL PARTICLE DISPERSION | Q6ZSR9, PAM, ACMSD | MAPK1 2082/4885TSHR 1718/4885HPGD 1258/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.